Clinical Trial Results:
An Open Label Randomized Multicentre Phase IIIb Trial Comparing Parenteral Substitution
versus Best Supportive Nutritional Care
in Subjects with Pancreatic Adenocarcinoma
Receiving 5-FU plus Oxaliplatin as 2nd or Higher Line Chemotherapy Regarding Clinical Benefit
Summary
|
|
EudraCT number |
2008-004696-22 |
Trial protocol |
DE |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
04 Nov 2020
|
First version publication date |
04 Nov 2020
|
Other versions |
|
Summary report(s) |
Final Study Report PANUSCO-Trial |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.